Typhoid 1 vaccine price in india

BHUBANESWAR -- Indian Prime Minister Narendra Modi was inoculated with the first dose of a home-grown coronavirus vaccine on Monday, kicking off an expansion of the country’s immunisation campaign as infections rise in some big states. People above 60, and those who are 45 or more and suffering from certain medical conditions, are now eligible for the vaccinations. But some inoculation centres reported issues with the government’s Co-Win portal used to coordinate the drive, which could slow its progress. India, which has reported the highest number of COVID-19 cases after the United States, has so far vaccinated 12 million health and front-line workers since starting its immunisation programme in mid-January. It wants to cover 300 million of its 1.35 billion people by August. “I appeal to all those who are eligible to take the vaccine,” 70-year-old Modi said on Twitter, posting a picture of him getting the shot at a government hospital in New Delhi. “Together, let us make India COVID-19 free!” The government said last week it would let people choose their vaccination centres, effectively letting beneficiaries pick either the home-grown COVAXIN shot or the AstraZeneca vaccine, unlike earlier. The inoculation campaign has run slower than expected due to a reluctance of health and front-line workers to take COVAXIN, which was approved without late-stage efficacy data. Only about 11% of vaccinated people have opted for the product developed by Bharat Biotech and the state-run Indian Council of Medical Research. Bharat Biotech has said efficacy data from a late-stage trial on nearly 26,000 volunteers who took COVAXIN will be out soon. The company, along with India’s drug regulator, says COVAXIN is safe and effective, based on early and intermediate studies. “Inspired and humbled by Hon’ble PM’s remarkable commitment to build an Aatmanirbhar Bharat,” Bharat Biotech said in reply to Modi’s tweet, referring to his self-reliance pitch to back local products. …

[Read more...] about Modi takes home-grown vaccine as India widens immunisation drive

The Hanoitimes - Vietnam is currently among top 25 destinations for Indian pharmaceutical products. The US$7-billion pharmaceutical market of Vietnam is a promising consumer of India which is known as the “Pharmacy of the World”. India  - "the Pharma of the World". Source: Embassy of India, Dublin Vietnam’s pharmaceuticals demand is expected to grow 8% annually till 2024. While Vietnamese drug manufacturers are able to meet half of their domestic demand, they depend on imports for approximately 60% of pharmaceutical end products, 90% of active pharmaceutical ingredients and most of the raw materials for the production of pharmaceuticals. India is the largest producer of generic drugs, supplying more than 60% of global demand for various vaccines. Over 80% of the antiretroviral drugs used globally to combat HIV-AIDS are manufactured by Indian pharmaceutical firms. The total size of the industry was estimated at around US$43 billion in 2019-2020 and is likely to reach US$55 billion in 2022. India has the advantage of a large raw material base, skilled workforce and increasing investment in research and development, that has enabled India to become a manufacturer of world-class medicines for its domestic consumption as well as overseas market. Touching upon the importance of the pharmaceutical sector in trade and healthcare partnership between India and Vietnam, Indian Ambassador to Vietnam Pranay Verma urged businesses and all other stakeholders on both sides to explore new opportunities for promoting engagement in pharmaceutical sector. India's Ambassador to Vietnam Pranay Verma. Photo: Embassy of India in Hanoi Speaking at “India-Vietnam Seminar on Promotion of Trade and Investment in Pharmaceutical Sector” held in Hanoi on January 21, the ambassador pointed out several reasons for the promising cooperation. Pharmaceuticals is a sector which occupies an important place in the bilateral trade relations …

[Read more...] about Vietnam: potential market for India pharmaceuticals

Vietnam will receive 4.8 to 8.2 million of AstraZeneca COVID-19 vaccine doses AZD1222 for free, which are shared by COVID-19 Vaccines Global Access (COVAX), a global initiative Vietnam has engaged, the Ministry of Health said on Sunday. COVAX, which aims at equitable access to COVID-19 vaccines, is led by the Global Alliance for Vaccines and Immunization, the World Health Organization, the Coalition for Epidemic Preparedness Innovations, and others. The doses are said to arrive in Vietnam in batches from now to the second quarter of this year and will be given for free. The Ministry of Health has assigned the General Department of Preventive Medicine to draw a plan on using COVID-19 vaccince. According to Nguyen Minh Hang, deputy head of the department, the plan is expected to be finished this week. “The first prioritized group to get the vaccination is medical staff members who are participating in combating the pandemic and treating COVID-19 patients,” Nguyen said. “Then, we will move to the next groups.” In Vietnam, AZD1222 is used to vaccinate people aged 18 to 60. Earlier, Vietnam also ordered to buy 30 million of doses of AstraZeneca vaccine which are expected to arrive in Vietnam in batches within this quarter. The vaccination price has yet to be revealved. Besides the imported vaccine, four domestic manufacturers are currently researching and developing namde-in-Vietnam COVID-19 vaccine, of which two units are conducting human trial on volunteers. Like us on Facebook or follow us on Twitter to get the latest news about Vietnam! …

[Read more...] about Vietnam to receive up to 8 million doses of free COVID-19 vaccine